Literature DB >> 18955403

Predicting response to CRT. The value of two- and three-dimensional echocardiography.

Nina Ajmone Marsan1, Ole A Breithardt, Victoria Delgado, Matteo Bertini, Laurens F Tops.   

Abstract

Recently, it has been suggested that a direct assessment of left ventricular (LV) mechanical dyssynchrony may improve the selection of candidates to cardiac resynchronization therapy (CRT). In fact, when the established clinical and electrocardiographic selection criteria are applied, response to CRT may vary widely and up to one-third of the patients fail to benefit from CRT. Echocardiography has been extensively applied to assess LV dyssynchrony and to predict favourable response to CRT, using different two- and three-dimensional modalities. In this review, the value of these echocardiographic modalities will be discussed, highlighting the advantages and drawbacks of each technique and evaluating the clinical implications and future perspectives of LV dyssynchrony assessment.

Entities:  

Mesh:

Year:  2008        PMID: 18955403     DOI: 10.1093/europace/eun219

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  3 in total

1.  Mechanical left ventricular dyssynchrony detection by endocardium displacement analysis with 3D speckle tracking technology.

Authors:  Chi Hion Li; Francesc Carreras; Rubén Leta; Lidia Carballeira; Sandra Pujadas; Guillem Pons-Lladó
Journal:  Int J Cardiovasc Imaging       Date:  2010-08-14       Impact factor: 2.357

Review 2.  Left ventricular reverse remodelling and its predictors in non-ischaemic cardiomyopathy.

Authors:  Tomas Hnat; Josef Veselka; Jakub Honek
Journal:  ESC Heart Fail       Date:  2022-04-18

Review 3.  Ventricular Dyssynchrony and Pacing-induced Cardiomyopathy in Patients with Pacemakers, the Utility of Ultra-high-frequency ECG and Other Dyssynchrony Assessment Tools.

Authors:  Jan Mizner; Pavel Jurak; Hana Linkova; Radovan Smisek; Karol Curila
Journal:  Arrhythm Electrophysiol Rev       Date:  2022-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.